中文名稱： 鹽酸*,CAS：1404-93-9
中文別名： *鹽酸鹽
英文名稱： Vancomycin hydrochloride
英文別名： (3S-(3R*,6S*(S*),7S*,22S*,23R*,26R*,36S*,38aS*))-3-(2-Amino-2-oxoethyl)-44-((2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl)oxy)-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-((4-methyl-2-(methylamino)-1-oxopentyl)amino)-2,5,24,38,39-pentaoxo-22H-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35-dimetheH,16H-(1,6,9)oxadiazacyclohexadecino(4,5-m)(10,2,16)benzoxadiazacyclotetracosine-26-carboxylic acid, monohydrochloride; Vancomycin HCl; Vancomycin monohydrochloride; Vancor; UNII-71WO621TJD; Vancocine hydrochloride; Vancocin hydrochloride; 48-({3-[(4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl}oxy)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-{[4-methyl-2-(methylamino)pentanoyl]amino}-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2~3,6~.2~14,17~.1~8,12~.1~29,33~.0~10,25~.0~34,39~]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid hydrochloride (1:1) (non-preferred name); (1S,2R,18R,19R,22S,25R,28R,40S)-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-{[(2R)-4-methyl-2-(methylamino)pentanoyl]amino}-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2~3,6~.2~14,17~.1~8,12~.1~29,33~.0~10,25~.0~34,39~]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid (non-preferred name); (1S,2R,18R,19R,22S,25R,28R,40S)-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-{[(2R)-4-methyl-2-(methylamino)pentanoyl]amino}-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid hydrochloride (non-preferred name)
CAS號(hào)： 1404-93-9
EINECS號(hào)： 215-772-6
分子式： C66H76Cl3N9O24
分子量： 1485.7145
規(guī) 格： 100mg
InChI： InChI=1/C66H75Cl2N9O24.ClH/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92;/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95);1H/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-;/m0./s1
分子結(jié)構(gòu)： 鹽酸* 1404-93-9
點(diǎn)擊看大圖
產(chǎn)品用途：
抗菌譜窄，主要對(duì)革蘭陽(yáng)性菌有效
危險(xiǎn)性標(biāo)志: Xi:Irritant;
風(fēng)險(xiǎn)術(shù)語(yǔ)： R43:;
安全術(shù)語(yǔ)： S24/25:;
鹽酸*,CAS：1404-93-9專業(yè)的管理方案：
1) 科學(xué)的質(zhì)量管理：建立了從供應(yīng)商篩選、原料精選、生產(chǎn)過程環(huán)環(huán)相扣的控制流程、從原料到入庫(kù)檢驗(yàn)的質(zhì)控程序，并形成一整套完備的質(zhì)管系統(tǒng)。
2) 專業(yè)的產(chǎn)品包裝：適應(yīng)產(chǎn)品特性的包裝物形狀及材質(zhì)，防漏、防滲、防震、防潮等功能為一體，使用方便，運(yùn)輸安全。
3) 高標(biāo)的倉(cāng)儲(chǔ)中心：運(yùn)用智能化檢測(cè)系統(tǒng)，保障倉(cāng)庫(kù)的溫度、濕度、及通風(fēng)條件；冷藏、暗室及劇毒產(chǎn)品分庫(kù)存放，保證產(chǎn)品的性質(zhì)穩(wěn)定。
4) 嚴(yán)格的質(zhì)量控制：嚴(yán)格分析每一批產(chǎn)品，產(chǎn)品有效期前3個(gè)月進(jìn)行復(fù)檢，確保更佳的批次重現(xiàn)性。
市場(chǎng)業(yè)務(wù)遍布全國(guó)各地，為廣大客戶提供、zui快的服務(wù)和優(yōu)質(zhì)產(chǎn)品而不懈努力，以優(yōu)質(zhì)的產(chǎn)品和有競(jìng)爭(zhēng)力的價(jià)格取勝，與國(guó)內(nèi)生產(chǎn)廠家和國(guó)外客戶間建立了*穩(wěn)定的合作關(guān)系，按照規(guī)范化管理的生產(chǎn)基地，利用自身優(yōu)勢(shì)營(yíng)銷平臺(tái)，目前已同眾多實(shí)驗(yàn)室建立了良好的合作關(guān)系。
會(huì)員1.png)
